Angiotensin I-converting enzyme isoforms (high and low molecular weight) in urine of premature and full-term infants

Hypertension

Volumn 35, Issue 6, 2000, Pages 1284-1290

  Hattori, Monica A ^a   Del Ben, Graziela L ^a   Carmona, Adriana K ^a   Casarini, Dulce Elena ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin converting enzyme; Infants, full term; Infants, premature; Nephrogenesis; Urine

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HYPERTENSION; INFANT; KIDNEY DEVELOPMENT; NORMAL HUMAN; PREMATURITY; PRIORITY JOURNAL;

EID: 0034124227     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.6.1284     Document Type: Article

References (45)

1. Yang HYY, Erdös EG, Levin V. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochem Biophys Acta. 1970;214:374-376.
2. Skidgel RA, Erdös EG. The broad substrate specificity of human angiotensin I converting enzyme. Clin Exp Hypertens [A]. 1987;A9:243-259. Review.
3. Skidgel RA, Engelbrench S, Johnson AR, Erdös EG. Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peptides. 1984;5:769.
4. Kokubo T, Kato I, Nishimura K, Hiwada K, Ueda E. Angiotensin converting enzyme in urine. Clin Chem Acta. 1978;9:375-379.
5. Casarini DE, Carmona AK, Plavinik FL, Juliano L, Zanella MT, Ribeiro AB. Effects of calcium blockers as inhibitors of angiotensin I-converting enzyme. Hypertension. 1995;26(pt II):1145-1148.
6. Ryan JW, Oza MB, Martin LC, Pena GA. Components of the kallikrein-kinin system in urine. In: Fuji S, Moryia H, Suzuki T, eds. Kinins II: Biochemistry, Pathophysiology and Clinical Aspects. New York, NY: Plenum Press; 1978; 10: 313-323.
7. Erdös EG. Angiotensin I-converting enzyme and the changes in our concepts through the years. Hypertension. 1990;16:363-370.
8. Bünning P, Riordan JF. Activation of angiotensin converting enzyme by monovalent anions. Biochemistry. 1983;22:110-116.
9. Deddish PA, Wang L, Jackman HL, Michel B, Wang J, Skidgel RA, Erdös EG. Single domain angiotensin I converting enzyme (kininase II): characteristics and properties. J Pharmacol Exp Ther. 1996;279: 1582-1589.
10. Dzau VJ. Tissue renin-angiotensin system: physiologic and pharmacologic implications: introduction. Circulation. 1988;77(pt 2):I1-I3.
11. Erdös EG, and Skidgel RA. The angiotensin I-converting enzyme. Lab Invest. 1987;56:345-348.
12. Wolf G. Angiotensin as a renal growth promoting factor. Adv Exp Med Biol. 1995;377:225-236.
13. Casarini DE, Boim MA, Stella RCR, Krieger-Azzolini MH, Krieger JE, Schor N. Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am J Physiol. 1997;272:F405-F409.
14. Andrade MC, Quinto BM, Carmona AK, Ribas OS, Boim MA, Schor N, Casarini DE. Purification and characterization of angiotensin I-converting enzymes from mesangial cells in culture. J Hypertens. 1998;16(pt 2):2063-2074.
15. Braam B, Mitchell KD, Fox J, Navar LG. Proximal tubular excretion of angiotensin II in rats. Am J Physiol. 1993;264:F891-F898.
16. Ching SF, Hayes LW, Slakey LL. Angiotensin converting enzyme in cultured endothelial cells and growth medium: relationship to enzyme from kidney and plasma. Biochim Biophys Acta. 1981;657:222-231.
17. Del Vecchio PJ, Smith JR. Expression of angiotensin-converting enzyme activity in cultured pulmonary artery endothelial cells. J Cell Physiol. 1981;108:337-345.
18. Costerousse O, Allegrini J, Huang H, Bounhik J, Alhenc-Gelas F. Regulation of ACE gene expression and plasma levels during rat postnatal development. Am J Physiol. 1994;267:E745-E753.
19. Yosipiv IV, Dipp S, el-Dahr SS. Ontogeny of somatic angiotensin-converting enzyme. Hypertension. 1994;23:369-374.
20. Cambien F, Alhenc-Gelas F, Herbeth B, Andre JL. Rokotovao R, Gonzales MF, Allegrini J, Bloch C. Familial resemblance of plasma angiotensin I-converting enzyme level: the Nancy study. Am J Hum Genet. 1988;43:774-780.
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
22. Friedland J, Silverstein E. A sensitive fluorometric assay for serum angiotensin converting enzyme. Am J Clin Pathol. 1976;66:416-424.
23. Leatherbarrow RJ. Grafit version 3.0. Staines, UK: Erithacus Software Ltd. 1992.
24. Laemmli UK. Cleavage of structure proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
25. Erdös EG. Skidgel RA. Structure and function of human angiotensin converting enzyme (kininase II). Biochem Soc Trans. 1985;13:42-44.
26. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A. 1988; 85:9386-9390.
27. Hooper NM, Turner AJ. Isolation of two differentially glycosylated forms of peptidyl-dipeptidase A (angiotensin converting enzyme) from pig brain: a re-evaluation of their role in neuropeptide metabolism. Biochem Pharmacol. 1987;51:11-14.
28. Deddish PA, Wang J, Michel B, Morris PW, Davidson NO, Skidgel RA, Erdos EG. Naturally occurring active N-domain of human angiotensin I-converting enzyme. Proc Natl Acad Sci U S A. 1994;91:7807-7811.
29. Ehlers MRW, Kirsh RE. Catalysis of angiotensin I hydrolysis by human angiotensin-converting enzyme: effect of chloride and pH. Biochemistry 1988;27:188-201.
30. Ehlers MRW, Riordan JF. Angiotensin I converting enzyme: Biochemistry and molecular biology. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology Diagnosis and Management. New York, NY: Raven Press; 1990:1217-1231.
31. Weare JA. Activation/inactivation of human ACE following chemical modifications of amino groups near the active site. Biochem Biophys Res Comm. 1982;104:1319-1326.
32. Nishimura K, Yoshida N, Hiwada K, Ueda E, Kokubu T. Properties of three different forms of angiotensin I-converting enzyme from human lung. Biochem Biophys Acta. 1978;522:229-237.
33. Wei L, Alhenc-Gelas F, Corvol P, Clauser E. The two homologous domains of human angiotensin I converting enzyme are both catalytically active. J Biol Chem. 1991;266:9002-9008.
34. 4OH. Arch Biochem Biophys. 1983;227:188-201.
35. Lanzillo JL, Stevens J, Dasarathy Y, Yotsumoto H, Fanburg BL. Angiotensin I-convening enzyme from human tissues. J Biol Chem. 1985;260: 14938-14944.
36. Danilov S, Jaspard E, Churakova T, Towbin H, Savoie F, Wei L, Alhenc-Gelas F. Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. J Biol Chem. 1994;269: 26806-26814.
37. Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes; angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci. 1993;52:1461-1480.
38. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996;27(pt 2):523-528.
39. DelliPizzi A, Hilchey SD, Bell-Quilley CP. Natriuretic action of angiotensin-(1-7). Br J Pharmacol. 1994;111:1-3.
40. Handa FK, Ferrario CM, Strandhoy JW. Renal actions of angiotensin-(1-7): in vivo and in vitro studies. Am J Physiol. 1996;270:F141-F147.
41. Chappell MC, Pirro NT, Sykes A, Ferrario CM. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension. 1998;31(pt 2):362-367.
42. Deddish PA, Marcic B, Jackman HL, Wang HZ, Skidgel RA, Erdos EG. N-domain specific substrate and C-domain inhibitors of angiotensin I converting enzyme, angiotensin 1-7 and keto-ACE. Hypertension. 1998; 31:912-917.
43. Rousseau A, Michaud A, Chauvet MT, Lenfand M, Corvol P. The hemoregulatory peptide N-acetyl-Ser-Asp- Lys-Pro is a natural and specific substrate of N-terminal active site of human ACE. J Biol Chem. 1995;270:3656-3661.
44. Azizi M, Rousseau A, Ezan E, Guyene T-T, Michelet S, Grognet J-M, Lenfant M, Corvol P, Ménard J. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest. 1996;97:839-844.
45. Bissinger RL. Renal physiology part 1: structure and function. Neonatal Network. 1995;14:9-20.